Status:

TERMINATED

Spinal Cord Injury Leg Rehabilitation

Lead Sponsor:

Oregon Health and Science University

Collaborating Sponsors:

Shepherd Center, Atlanta GA

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Spinal Cord Injury

Paraplegia

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to determine if individuals with incomplete spinal cord injury (SCI) who remain unable to walk normally 1 year after their SCIs are able to sense and move the affected leg...

Detailed Description

Traumatic spinal cord injury (SCI) affects over 200,000 people in the USA, with several thousand new injuries each year. Most recovery, following SCI, occurs in the six months following surgery. Furth...

Eligibility Criteria

Inclusion

  • Paraplegia or tetraplegia due to SCI
  • At least 1 year post incomplete Spinal Cord Injury
  • Can tolerate sitting upright for at least one hour
  • Capable of weight-bearing and taking a step with or without an assistive device
  • On the ASIA sensory function (light touch), a score of at least 1 at the L4 and L5 level
  • Primary ASIA Motor Criterion (PAMC) a total score of 4-12 for hip extensors, knee extensors, ankle dorsiflexors and ankle plantarflexors, with a minimum score of 1 for each of these muscles in the qualifying leg

Exclusion

  • Fracture of the treated limb resulting in loss of range of motion
  • Concomitant TBI or stroke (Patients who sustained mild head injury during the trauma with no evidence of structural abnormalities on brain images will qualify for the study), or other neurological injury or disease
  • DVT of the treated extremity
  • Peripheral nerve injury of the treated extremity
  • Osteo- or rheumatoid-arthritis limiting range of motion
  • Contractures equal to or greater than 50% of the normal ROM
  • Skin condition not tolerant of device or sitting upright
  • Progressive neurodegenerative disorder
  • Botox treatment of the treated extremity in the prior 5 month
  • Chronic ITB therapy
  • Uncontrolled seizure disorder
  • Uncontrolled high blood pressure/angina
  • Pain in affected limb or exercise intolerance
  • Participation in another therapy or activity-based program
  • Combined score on ASIA motor function for knee extensors, ankle dorsiflexors and ankle plantarflexors outside the range of 3-9

Key Trial Info

Start Date :

November 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2016

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT01498991

Start Date

November 1 2011

End Date

November 1 2016

Last Update

May 24 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Shepherd Center, Crawford Research Center

Atlanta, Georgia, United States, 30309

2

Oregon Health and Science University

Portland, Oregon, United States, 97239